Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹254 Cr.
Stock P/E
14.6
P/B
4.3
Current Price
₹115.1
Book Value
₹ 26.5
Face Value
10
52W High
₹137
52W Low
₹ 109.5
Dividend Yield
0%

Pramodini Medicare Overview

Business

Pramodini Medicare Ltd. operates in the Hospital & Healthcare Services sector in India. As a healthcare service provider, its core business involves offering medical care, diagnostic services, surgical procedures, and other related health services to patients. The company likely operates hospitals or clinics, providing both inpatient (hospitalization) and outpatient (consultations, day-care procedures) services. It generates revenue primarily through fees for medical consultations, surgeries, diagnostic tests, pharmacy sales, room charges, and potentially through agreements with health insurance providers for cashless treatments.

Revenue Mix

While specific breakdowns for Pramodini Medicare Ltd. are not available from the provided information, typical revenue segments for a hospital and healthcare services company in India include:

Inpatient Services: Revenue from hospitalized patients, including room charges, nursing care, surgical fees, and intensive care.

Outpatient Services: Revenue from consultations, diagnostic tests (pathology, radiology), health check-ups, and minor procedures performed without hospitalization.

Pharmacy: Revenue from selling medicines and medical supplies to both inpatients and outpatients.

Other Services: This may include specialized clinics, wellness programs, or medical tourism services.

The exact contribution of each segment to Pramodini Medicare Ltd.'s total revenue is unknown.

Industry

The Indian healthcare industry is characterized by strong growth, driven by an increasing population, rising income levels, higher health awareness, and improving insurance penetration. It is a highly fragmented market with a mix of large corporate hospital chains, standalone hospitals, and numerous small clinics. The quality and accessibility of healthcare vary significantly across urban and rural areas, and between different tiers of cities. Without specific details on its size, geographical focus, or specialization, Pramodini Medicare Ltd. likely operates either as a regional chain or a significant standalone hospital in a particular city or state in India. It would compete with other local hospitals, larger corporate chains expanding into its operating region, and specialized clinics. Its positioning would depend on its reputation, service quality, doctor panel, and affordability.

MOAT

Without specific company details, potential competitive advantages (moats) for a healthcare provider like Pramodini Medicare Ltd. could include:

Brand Reputation & Trust: A long-standing history of quality care and positive patient outcomes can build strong trust within a local community.

Specialized Expertise: A strong panel of renowned doctors or specialized centers of excellence for particular treatments can attract patients.

Strategic Location: Being easily accessible in a densely populated area or a region with underserved medical needs.

Patient Switching Costs (Low): While patients can switch hospitals, for chronic conditions or ongoing care, the inconvenience and desire for continuity can create a soft switching cost.

Operational Scale (Potentially): If it operates multiple facilities, it might achieve better procurement costs for equipment and medicines.

It is uncertain which of these, if any, Pramodini Medicare Ltd. currently possesses as a durable moat.

Growth Drivers

Key factors that can drive growth for Pramodini Medicare Ltd. over the next 3-5 years include:

Increasing Healthcare Expenditure: Rising disposable incomes and greater health awareness lead to higher spending on healthcare services.

Aging Population & Lifestyle Diseases: A growing elderly population and the rise of chronic and lifestyle-related diseases necessitate more medical interventions.

Government Initiatives: Schemes like Ayushman Bharat (PMJAY) can expand the payer base and increase demand for hospital services, particularly from economically weaker sections.

Health Insurance Penetration: Growing penetration of private and government-backed health insurance reduces out-of-pocket expenses for patients, encouraging more hospital visits.

Medical Tourism: For quality hospitals, attracting patients from other countries or regions within India seeking specialized treatments at competitive prices.

Expansion & Upgrades: Investing in new facilities, increasing bed capacity, adding specialized departments, or upgrading technology.

Risks

Key business risks for Pramodini Medicare Ltd. include:

Intense Competition: The Indian healthcare market is highly competitive, with both organized corporate chains and numerous unorganized players vying for patients.

Regulatory & Pricing Pressures: Government interventions regarding pricing caps for procedures, medicines, or medical devices can impact profitability. Strict quality standards and compliance requirements also pose risks.

Manpower Shortages: Shortages of skilled doctors, nurses, and allied healthcare professionals can impact service quality and operational costs.

High Capital Expenditure: Setting up and expanding hospitals requires significant capital investment, leading to high debt or equity dilution.

Reputational Risk & Medical Malpractice: Any incidents of medical negligence or adverse patient outcomes can severely damage reputation and lead to legal liabilities.

Technology & Equipment Obsolescence: The need for continuous investment in advanced medical technology to remain competitive.

Pandemic/Epidemic Impact: While potentially increasing demand, large-scale health crises can also disrupt elective procedures and strain resources.

Management & Ownership

As a publicly listed company in India, Pramodini Medicare Ltd. would have promoter (founder) ownership and institutional/public shareholding. The specific quality of management (experience, track record, corporate governance practices) for Pramodini Medicare Ltd. is not ascertainable from the provided information. However, the promoter group typically holds a significant stake and plays a crucial role in the strategic direction and long-term vision of Indian companies. Public shareholders, including institutional investors and retail investors, make up the remaining ownership.

Outlook

Pramodini Medicare Ltd. operates in a structurally growing sector in India, driven by demographic trends and increasing healthcare demand. The bull case for the company hinges on its ability to effectively capitalize on this industry growth by expanding its services, maintaining high-quality patient care, attracting and retaining skilled medical professionals, and navigating the evolving regulatory landscape. Successful execution of expansion plans and building a strong regional brand could lead to sustained revenue and profit growth.

However, the bear case considers the inherent challenges of the Indian healthcare sector, including intense competition, the constant need for capital expenditure, potential government pricing interventions, and the difficulty of scaling high-quality human capital. Without specific information on its operational efficiency, financial strength, and market positioning, the company faces the risk of being outmaneuvered by larger, more resourced competitors or struggling with profitability amidst price controls and rising input costs. Its ability to carve out a niche or build a robust reputation will be critical for its long-term viability.

Pramodini Medicare Share Price

Live · NSE · Inception: 2000
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Pramodini Medicare Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Pramodini Medicare Profit & Loss

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 31 35 38 62
Other Income 0 1 0 1
Total Income 31 36 39 63
Total Expenditure 16 20 17 31
Operating Profit 15 16 21 32
Interest 2 2 1 1
Depreciation 5 4 4 7
Exceptional Income / Expenses 0 0 0 0
Profit Before Tax 7 10 16 23
Provision for Tax 2 3 5 6
Profit After Tax 6 7 11 17
Adjustments -2 -0 -0 0
Profit After Adjustments 4 7 11 17
Adjusted Earnings Per Share 2.6 4.2 6.6 10.4

Pramodini Medicare Balance Sheet

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 17 25 36 53
Minority's Interest 0 0 0 0
Borrowings 13 6 8 14
Other Non-Current Liabilities -2 -1 -1 -2
Total Current Liabilities 18 17 12 26
Total Liabilities 46 47 55 92
Fixed Assets 20 16 22 44
Other Non-Current Assets 4 9 14 14
Total Current Assets 21 22 19 33
Total Assets 46 47 55 92

Pramodini Medicare Cash Flow

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 1 3 1 6
Cash Flow from Operating Activities 7 10 22 25
Cash Flow from Investing Activities -4 -1 -15 -31
Cash Flow from Financing Activities -1 -11 -2 6
Net Cash Inflow / Outflow 2 -2 5 0
Closing Cash & Cash Equivalent 3 1 6 6

Pramodini Medicare Ratios

# Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 2.6 4.15 6.61 10.41
CEPS(Rs) 6.82 6.91 9.24 14.84
DPS(Rs) 0 0 0 0
Book NAV/Share(Rs) 10.03 14.82 21.43 31.84
Core EBITDA Margin(%) 47.98 44.1 54.83 49.61
EBIT Margin(%) 31.68 33.24 44.44 39.5
Pre Tax Margin(%) 24.44 28.6 41.19 37.41
PAT Margin (%) 19.21 20.26 29.13 27.9
Cash Profit Margin (%) 36.74 32.72 40.33 39.76
ROA(%) 12.89 15.42 21.92 23.76
ROE(%) 35.53 34.59 36.81 39.08
ROCE(%) 25.54 31.38 40.8 41.85
Receivable days 172.27 167.72 138.97 83.72
Inventory Days 0.31 0.29 1.1 3.49
Payable days 448.34 499.66 297 52.84
PER(x) 0 0 0 0
Price/Book(x) 0 0 0 0
Dividend Yield(%) 0 0 0 0
EV/Net Sales(x) 0.56 0.28 0.13 0.45
EV/Core EBITDA(x) 1.14 0.61 0.23 0.88
Net Sales Growth(%) 0 15.2 8.54 62.9
EBIT Growth(%) 0 20.87 45.13 44.78
PAT Growth(%) 0 21.51 56.05 55.99
EPS Growth(%) 0 59.72 59.12 57.58
Debt/Equity(x) 1.29 0.48 0.3 0.34
Current Ratio(x) 1.17 1.28 1.58 1.26
Quick Ratio(x) 1.17 1.28 1.56 1.22
Interest Cover(x) 4.38 7.17 13.67 18.89
Total Debt/Mcap(x) 0 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +63% +26% — —
Operating Profit CAGR +52% +29% — —
PAT CAGR +55% +42% — —
Share Price CAGR — — — —
ROE Average +39% +37% +37% +37%
ROCE Average +42% +38% +35% +35%

Pramodini Medicare Peer Comparison

Hospital & Healthcare Services Edit Columns

Pramodini Medicare Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Pramodini Medicare Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 37%
  • Debtor days have improved from 297 to 52.84days.
  • Company is almost debt free.

Cons

  • Stock is trading at 4.3 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp